EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Application of cancer organoids: The forefront of personalized oncology and preclinical testing

Lu-Qi Cao, Yuhao Xie, Yuhong Liu, John Wurpel, Leli Zeng, Zhe-Sheng Chen

Organoid Research · 2025-04-29 · 1 (2) · 025050008

DOI: 10.36922/or025050008 ↗
AbstractBibliografische Angaben

Abstract

Cancer remains one of the most pressing medical problems in the world. Recent years have seen a gradual rise in utilization of “organoids,” a novel in vitro three-dimensional culture technology, in cancer research. Organoids are multicellular structures derived from human stem cells, and cancer organoids can replicate the characteristics, morphology, and functionality of the original tumor in the human body. At present, organoid technology has been widely used in various oncologic contexts, including colorectal, liver, lung, pancreatic, and breast cancers, providing considerable assistance in patient-specific drug testing, precision medicine, and the development of personalized medical strategies. Therefore, this preclinical model contributes to significantly accelerating the translation from basic cancer research to clinical therapeutics. This review discusses the preparation of cancer organoids and their recent progress in multiple cancer research fields. Finally, the challenges of organoid technology in current clinical practice and future development prospects are discussed.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →